Related Experiment Video

Updated: Dec 27, 2025

A Method for Screening and Validation of Resistant Mutations Against Kinase Inhibitors
12:40

A Method for Screening and Validation of Resistant Mutations Against Kinase Inhibitors

Published on: December 7, 2014

15.1K

[Ruxolitinib in the treatment of two cases of chronic neutrophilic leukemia]

W S Zheng1, L X Guan1, L C Cheng1

  • 1Department of Hematology, Hainan Hospital of Chinese PLA General Hospital, Sanya 572000, China.

Zhonghua Zhong Liu Za Zhi [Chinese Journal of Oncology]
|March 6, 2020
PubMed
Abstract

No abstract available in PubMed .

Keywords:
Chronic neutrophilic leukemiaColony stimulating factor 3 receptorRuxolitinib

More Related Videos

Neutrophil Isolation and Analysis to Determine their Role in Lymphoma Cell Sensitivity to Therapeutic Agents14:04

Neutrophil Isolation and Analysis to Determine their Role in Lymphoma Cell Sensitivity to Therapeutic Agents

Published on: March 25, 2016

15.7K
Single-cell Analysis of Immunophenotype and Cytokine Production in Peripheral Whole Blood via Mass Cytometry12:36

Single-cell Analysis of Immunophenotype and Cytokine Production in Peripheral Whole Blood via Mass Cytometry

Published on: June 26, 2018

9.8K

Related Concept Videos

Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.6K